[Research advances of Huperzia serrata (Thunb.) Trev]
- PMID: 19938535
[Research advances of Huperzia serrata (Thunb.) Trev]
Abstract
Qiancengta, a traditional Chinese medicine produced from the whole plant of the club moss Huperzia serrata, has been used for a long history in China for treatment of a number of ailments, including contusions, strains, swellings, schizophrenia, myasthenia gravis and noworganophosphate poisoning. It has become known worldwide as a medicinal plant since Chinese scientists discovered huperzine A from it in the 1980s, which is reversible, potent and selective acetylcholine esterase (AChE) inhibitors by in vitro and in vivo pharmacological, and produce definite effects in the treatment of Alzheimer's disease. Now, Qiancengta is popular in all over the word for his famous pharmacological actions. For further exploitation this valuable resource under protection of nature environmental, its biological and ecological features, pharmaceutical active ingredients, artificial propagation and in vitro tissue culture, were reviewed, and the sustainable use of Qiancengta natural resource through plant biotechnology was put on the agenda.
Similar articles
-
Huperzine A from Huperzia species--an ethnopharmacolgical review.J Ethnopharmacol. 2007 Aug 15;113(1):15-34. doi: 10.1016/j.jep.2007.05.030. Epub 2007 Jun 2. J Ethnopharmacol. 2007. PMID: 17644292 Review.
-
[A novel phlegmariurine type alkaloid from Huperzia serrata (Thunb.) Trev].Yao Xue Xue Bao. 2003 Aug;38(8):596-8. Yao Xue Xue Bao. 2003. PMID: 14628450 Chinese.
-
A survey of potential huperzine A natural resources in China: the Huperziaceae.J Ethnopharmacol. 2006 Mar 8;104(1-2):54-67. doi: 10.1016/j.jep.2005.08.042. Epub 2005 Oct 3. J Ethnopharmacol. 2006. PMID: 16203116
-
Huperzine alkaloids from Australasian and southeast Asian Huperzia.Pharm Biol. 2010 Sep;48(9):1073-8. doi: 10.3109/13880209.2010.485619. Pharm Biol. 2010. PMID: 20731560
-
Development and application of medicinal plant tissue cultures for production of drugs and herbal medicinals in China.Nat Prod Rep. 2006 Oct;23(5):789-810. doi: 10.1039/b610767b. Epub 2006 Sep 12. Nat Prod Rep. 2006. PMID: 17003910 Review.
Cited by
-
Recent Advances in the Treatment and Management of Alzheimer's Disease: A Precision Medicine Perspective.Curr Top Med Chem. 2024;24(19):1699-1737. doi: 10.2174/0115680266299847240328045737. Curr Top Med Chem. 2024. PMID: 38566385 Review.
-
Targeting brain α7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status.CNS Drugs. 2014 Nov;28(11):975-87. doi: 10.1007/s40263-014-0201-3. CNS Drugs. 2014. PMID: 25248971 Review.